Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    25.00 (0.45%)
Bid:
5,400.00
Ask:
5,650.00
Spread: 250.00 (4.63%)
Market Cap: £139.03m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

8 Mar 2023 07:00

RNS Number : 2183S
Camellia PLC
08 March 2023
 

8 March 2023

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

Further to the trading announcement on 7 December there has been a significant improvement to our expectations for underlying profit before tax for the Group for 2022.

 

Negotiations on pay in Bangladesh have now concluded resulting in a government mandated payment of Tk11,000 per permanent worker (payable during 2023) and a pay increase of 41.7% effective from the beginning of August 2022. This is a significantly improved outcome than anticipated and will be reflected in our 2022 results.

 

In addition, trading in our agriculture division in the final quarter of the year has been ahead of our expectations due to:

· Higher net sales prices achieved for India, Bangladesh and Kenya teas

· Better net sales prices for avocados

· Improved net sales prices achieved for both soya and maize

· Tighter control of production and overhead costs across the division

· Offset in part by lower net sales prices for macadamia and Malawi teas

 

We also further reduced our head office overhead costs.

 

Revenue for continuing operations* for 2022 is now expected to be approximately £294 million. As a consequence of the factors set out above, excluding any financial results for BF&M for 2022, the Company now believes that the adjusted profit before tax for continuing operations** for the Group for 2022 will be approximately 10% below the reported adjusted profit before tax for continuing operations (including BF&M share of results for that year) for 2021 which was £8.8 million. This compares very favourably to the Company's previous guidance given on 7 December 2022.

 

BF&M is expected to announce its results in April 2023 and until that time, as a consequence of the impact of the volatility of equity and bond markets on BF&M's results, it is not possible for Camellia to forecast the likely full year outcome for BF&M with any certainty.

 

 

* continuing operations are all operations except for ACS&T which was sold at the end of 2022

** adjusted profit before tax for continuing operations seeks to present an indication of performance for continuing operations which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges, gains/losses on disposal of assets and restructuring costs.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGGFMNMGFZZ
Date   Source Headline
15th Aug 20197:00 amRNSHalf-year Report
7th Jun 201911:00 amRNSResult of AGM
6th Jun 201911:30 amRNSAGM Trading Statement
15th Apr 201912:13 pmRNSAnnual Report and Notice of AGM
11th Apr 20197:00 amRNSFinal Results
21st Mar 20194:40 pmRNSSecond Price Monitoring Extn
21st Mar 20194:35 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSTrading update
23rd Oct 20187:00 amRNSTrading Update
29th Aug 201811:40 amRNSInterim Report 2018
24th Aug 20187:00 amRNSHalf-year Report
8th Jun 201812:20 pmRNSResult of AGM
7th Jun 201811:30 amRNSAGM Trading Statement
25th Apr 20184:00 pmRNSAnnual Report and Notice of AGM
20th Apr 20181:57 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSFinal Results
21st Mar 20187:00 amRNSNotice of Results
22nd Dec 20179:42 amRNSDirectorate Change
6th Dec 201712:28 pmRNSTrading Statement
14th Nov 20173:00 pmRNSHolding(s) in Company
29th Aug 20173:20 pmRNSInterim report 2017
25th Aug 20177:00 amRNSHalf-year Report
2nd Jun 20171:13 pmRNSResult of AGM
1st Jun 201711:30 amRNSAGM Statement
11th May 20177:00 amRNSUpdate on Duncan Lawrie
2nd May 20172:05 pmRNSAnnual Financial Report
27th Apr 20177:00 amRNSFinal Results
21st Apr 20175:03 pmRNSUpdate on Duncan Lawrie
19th Dec 20167:00 amRNSUpdate on Duncan Lawrie
22nd Nov 20165:24 pmRNSHolding(s) in Company
30th Aug 20164:52 pmRNSHalf-year Report
25th Aug 201611:33 amRNSInterim Dividend 2016 - Record Date
25th Aug 20167:00 amRNSHalf-year Report
3rd Jun 20161:06 pmRNSResult of AGM
2nd Jun 201612:15 pmRNSAGM Statement
4th May 20161:12 pmRNSHolding(s) in Company
3rd May 20162:34 pmRNSAnnual Report and Notice of Annual General Meeting
29th Apr 20164:03 pmRNSDirector/PDMR Shareholding
28th Apr 20167:00 amRNSFinal Results
2nd Feb 20167:00 amRNSTrading Statement
12th Nov 201510:06 amRNSDirector/PDMR Shareholding
9th Nov 20157:00 amRNSSale of Loddon Engineering Limited
14th Sep 20152:08 pmRNSHalf Yearly Report
27th Aug 20157:00 amRNSHalf Yearly Report
27th Jul 20157:00 amRNSChange of Adviser
2nd Jul 20152:09 pmRNSBoard changes
5th Jun 201512:29 pmRNSResult of AGM
4th Jun 201511:30 amRNSAGM Statement
28th Apr 20153:45 pmRNSReport and Accounts
23rd Apr 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.